Recall Radar
All recallsMedicine & devices

Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03, c) 1000 Capsules, NDC 27241-098-10, Marketed by: Ajanta Ph…

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

Class II Medicine & devices FDA May 13, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Ajanta Pharma Ltd. — Aurangabad
Severity
Class II — moderate
Reported
May 13, 2026
Quantity
312,894 packs
Recall number
D-0514-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within U.S

Other medicine & devices recalls

See every current recall on the live dashboard →